10 drugs to watch this year
March 15, 2016 6:05 AM
10 drugs to watch in 2016
Generic drugs are usually significantly cheaper for plan sponsors than brand-name drugs. Here’s a look at 10 drugs coming off patent in 2016. And although the FDA hasn’t yet approved generics for many of the following blockbuster drugs that are coming off patent this year, in most cases there are generics in the pipeline, according to Dickson Data Blog .
1. Humira
Used for: Rheumatoid arthritis
Manufactured by: Abbvie
Estimated annual sales: $12.54 billion
Generic approved: Biosimilars in the pipeline; no generic approved
Manufactured by: Abbvie
Estimated annual sales: $12.54 billion
Generic approved: Biosimilars in the pipeline; no generic approved
2. Crestor
Used for: Lower bad cholesterol (LDL), raise good cholesterol (HDL)
Manufactured by: AstraZeneca
Estimated annual sales: $6.4 billion
Generic approved: N/A
Manufactured by: AstraZeneca
Estimated annual sales: $6.4 billion
Generic approved: N/A
3. Benicar
Used for: High blood pressure
Manufactured by: Daiichi Sankyo
Estimated annual sales: $2.6 billion
Generic approved: N/A
Manufactured by: Daiichi Sankyo
Estimated annual sales: $2.6 billion
Generic approved: N/A
4. Zetia
Used for: High cholesterol
Manufactured by: Merck
Estimated annual sales: $2.6 billion
Generic approved: N/A
Manufactured by: Merck
Estimated annual sales: $2.6 billion
Generic approved: N/A
5. Seroquel XR
Used for: Schizophrenia and bipolar disorder
Manufactured by: AstraZeneca
Estimated annual sales: $1.3 billion
Generic approved: N/A
Manufactured by: AstraZeneca
Estimated annual sales: $1.3 billion
Generic approved: N/A
6. AcipHex Sprinkle
Used for: Acid reflux, ulcers
Manufactured by: Eisai
Estimated annual sales: $1.2 billion
Generic approved: November 2013
Manufactured by: Eisai
Estimated annual sales: $1.2 billion
Generic approved: November 2013
7. Epzicon
Used for: HIV
Manufactured by: Viiv Healthcare
Estimated annual sales: $1.1 billion
Generic approved: N/A
Manufactured by: Viiv Healthcare
Estimated annual sales: $1.1 billion
Generic approved: N/A
8. Kaletra
Used for: HIV
Manufactured by: Abbott
Estimated annual sales: $1 billion
Generic approved: N/A
Manufactured by: Abbott
Estimated annual sales: $1 billion
Generic approved: N/A
9. Norvir
Used for: HIV
Manufactured by: Abbott
Estimated annual sales: $962 million
Generic approved: Jan. 15, 2015
Manufactured by: Abbott
Estimated annual sales: $962 million
Generic approved: Jan. 15, 2015
10. Ambisome
Used for: Anti-fungal medicine
Manufactured by: Gilead
Estimated annual sales: $493 million
Generic approved: N/A
Manufactured by: Gilead
Estimated annual sales: $493 million
Generic approved: N/A
